Psoriasis Drug Soriatane Eases Bone Defects in Zebrafish CEP Model

Psoriasis Drug Soriatane Eases Bone Defects in Zebrafish CEP Model

295230

Psoriasis Drug Soriatane Eases Bone Defects in Zebrafish CEP Model

Soriatane (acitretin), a medication normally used to treat the skin disorder psoriasis, was found to alleviate bone defects in a new zebrafish model of congenital erythropoietic porphyria, or CEP, a study reports. The medicine worked to ease bone defects driven by the accumulation of the molecule uroporphyrin-I in the bones. In addition to providing the porphyria community with a new animal model of the disease — important for research — the scientists noted that data from this…

You must be logged in to read/download the full post.